Regenecure

Company Overview

Snapshot

Founded in May 2010, Regenecure operates with 1–10 employees. The company has raised $3.5 million across one funding round, focusing on developing solutions for bone reconstruction.

Business overview

Regenecure is a Health Tech & Life Sciences company dedicated to developing and marketing solutions for bone reconstruction. Its core technology involves regenerative, biocompatible, polymeric membrane implants made of microporous ammonio methacrylate copolymer type A and a plasticizer. These implants facilitate stem cell adherence, proliferation, and differentiation into bone tissue, serving as an effective barrier to prevent connective tissue infiltration. The company's product, BoneCure, is designed to span large, segmental bone defects and can also act as a delivery system for cells and active agents. Regenecure operates in the Biomaterials & Tissue Engineering sector, serving markets such as the United States, Australia, the United Kingdom, Germany, and Canada.

Company Intelligence Q&A

What is Regenecure's primary focus?

Regenecure is dedicated to developing and marketing solutions for bone reconstruction, utilizing regenerative polymeric membrane implants.

What is the core technology behind Regenecure's implants?

The core technology involves microporous ammonio methacrylate copolymer type A and a plasticizer, forming a membrane that facilitates stem cell adherence and differentiation into bone tissue.

What is the function of Regenecure's membrane implant?

The membrane implant serves as an effective barrier to prevent connective tissue infiltration, allowing for excellent proliferation and differentiation of mesenchymal stem cells (MSCs) into bone tissue, and can be shaped for various bone defects.

What is the name of Regenecure's product?

Regenecure's product is named BoneCure, a regenerative, biocompatible, polymeric membrane implant designed for bone reconstruction.

In which markets does Regenecure operate?

Regenecure operates in geomarkets including the United States, Australia, the United Kingdom, Germany, and Canada.